Topic: Mitochondrial function

Supervisors: Professor Andrew Murray, Department of Physiology, Development and Neuroscience, University of Cambridge Dr Ross Lindsay, Novo Nordisk Funding: Fully funded PhD studentship (Home/UK tuition fees and stipend) supported by Novo Nordisk Proposed Start date: 5 January 2027 Project Overview Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately one in three adults worldwide and is rapidly becoming the leading cause of chronic liver disease. Beyond its effects on the liver, MASLD substantially increases the risk of cardiovascular disease, type 2 diabetes